Emerging Social Issues on Targeted Drug Delivery
The world of targeted drug delivery (TDD) represents an incredible leap forward in how we treat and manage diseases . It’s a frontier where science converges with hope, precision, and, in many ways, a reimagining of healthcare itself. As we move closer to realizing a future where therapies can target specific cells or tissues with minimal side effects, the excitement is tempered by a growing recognition of the technical, ethical, and societal challenges that come with this revolutionary shift in medical practice. In this drawing from the insights of researchers and thinkers who are deeply engaged in navigating this transformative field. Together, the following chapters, illustrate how the evolving landscape of TDD holds both immense promise and significant complexity.
Sample Chapter(s)
Ebook (10294 KB)
Components of the Book:
  • Chapter 1. Emerging Social Issues on Targeted Drug Delivery
  • Chapter 2. Nanomedicine and Nanoparticle Drug Delivery Systems.
  • Chapter 3. The Societal Impact of Nanomedicine
  • Chapter 4. From Blindness to Awareness in Nanoethics: The Wireless Drug Delivery Case
  • Chapter 5. Drug Delivery to the Brain: State of the Art and Challenges
  • Chapter 6. Role of iRGD Peptide in Cancer Therapy and Targeted Drug Delivery
  • Chapter 7. Evolving Landscape on Sex Specific Status on Lung Cancer Management: Moderating Effects, Risk Assessment
  • Chapter 8. Nanoscience-Nanotechnology Education for All: Promoting Nano-Literacy across Educational Levels
  • Chapter 9. Post-COVID-19 Advancing Targeted Drug Delivery (TDD): Literature Insights and Market Dynamics
  • Chapter 10. Pioneering the Future of Drug Delivery
Readership: Students, academics, teachers and other people attending or interested in Social Issues on Targeted Drug Delivery.

Chapter 1. Emerging Social Issues on Targeted Drug Delivery
Prof. Aristidis M. Tsatsakis, Dr. Maria Vliora, Dr. Kallinteri Paraskevi, Dr. Mariel Kalkach-Aparicio
PDF (224 KB)

Chapter 2. Nanomedicine and Nanoparticle Drug Delivery Systems.
Catalin Zaharia, Ionut-Cristian Radu, Derniza-Elena Cozorici
PDF (1025 KB)

Chapter 3. The Societal Impact of Nanomedicine
Souhaila H. El Moukhtari, Adriana Rodríguez-Garrauz, Amaya Azqueta1, María J. Blanco-Prieto
PDF (904 KB)

Chapter 4. From Blindness to Awareness in Nanoethics: The Wireless Drug Delivery Case
Andreea-Iulia Someşan, Ion Copoeru
PDF (389 KB)

Chapter 5. Drug Delivery to the Brain: State of the Art and Challenges
João Leitão, Ana Cristóvão, Dina Pereira, Margarida Damasceno
PDF (272 KB)

Chapter 6. Role of iRGD Peptide in Cancer Therapy and Targeted Drug Delivery
Karthik Mangu, Sridivya Goud Kalali, Lakshmi Tulasi Naraharisetti, Chandraiah Godugu
PDF (683 KB)

Chapter 7. Evolving Landscape on Sex Specific Status on Lung Cancer Management: Moderating Effects, Risk Assessment
Himanshu Sharma, Monika Kaushik, Sumel Ashique, Arshad Farid, Farzad Taghizadeh-Hesary
PDF (560 KB)

Chapter 8. Nanoscience-Nanotechnology Education for All: Promoting Nano-Literacy across Educational Levels
Dimitris Pnevmatikos, Giorgos Peikos, Panagiota Christodoulou, Penelope Papadopoulou
PDF (435 KB)

Chapter 9. Post-COVID-19 Advancing Targeted Drug Delivery (TDD): Literature Insights and Market Dynamics
Romina Fucà, Serena Cubico, João Leitão, Giuseppe Favretto, Piermatteo Ardolino
PDF (1503 KB)

Chapter 10. Pioneering the Future of Drug Delivery
Vittorio Bava
PDF (351 KB)
Prof. Aristidis M. Tsatsakis
Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71003, Heraklion, Greece.

Dr. Maria Vliora
Discovery Foundation, Heraklion, Crete, Greece.

Dr. Kallinteri Paraskevi
Paraskevi Kallinteri Linguistic Services, Helsinki, Finland.

Dr. Mariel Kalkach-Aparicio
University of South Dakota/Sanford Medical Center, U.S., UNESCO Chair of Bio-ethics and Human Rights, ITA, Centro Anáhuac de Desarrollo Estratégico en Bioética, MEX.

Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top